Primary Care Physician "Successfully Removed"

U.S. President Joe Biden's lesion removed during a health checkup last month was confirmed to be basal cell carcinoma, a type of skin cancer. However, the White House announced on the 3rd (local time) that no additional treatment is necessary.


On the same day, White House physician Kevin O'Connor released a memo containing this information. Dr. O'Connor stated, "The small lesion removed from President Biden's chest during last month's health checkup was confirmed to be carcinoma," adding, "Biopsy results confirmed the lesion as basal cell carcinoma." Basal cell carcinoma is a type of skin cancer.

U.S. President Biden moving to undergo a health checkup. <br>Photo by AP Yonhap News

U.S. President Biden moving to undergo a health checkup.
Photo by AP Yonhap News

View original image

He continued, "All cancer-related tissue was successfully removed, and no further treatment is required," explaining, "Unlike melanoma or squamous cell carcinoma, basal cell carcinoma tends not to spread or metastasize, but there is a possibility that it can grow in size."


If the basal cell carcinoma grows larger, surgical removal may become more difficult, so President Biden will continue to undergo regular skin examinations as part of ongoing health management.


Earlier, on the 16th of last month, President Biden had a lesion on his chest removed during a routine health checkup.



Basal cell carcinoma, a malignant tumor originating from the non-keratinizing cells at the base of the epidermis and its appendages, is one of the most common non-melanoma skin cancers along with squamous cell carcinoma. Most lesions are identified on the skin surface, allowing for rapid detection of carcinoma development. It invades locally and very rarely metastasizes. The primary cause of occurrence is prolonged exposure to ultraviolet rays, and treatment is primarily surgical excision.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing